Importantly, in line with repository data and correlating with our RRAS2-overexpressing mice, we found a significant increase in RRAS2 mRNA levels in CLL patients compared to healthy subjects, with a mean of 5.3-fold higher expression in CLL patients (Fig. 5a). This evidence concerns the gene RRAS2 and B-cell chronic lymphocytic leukemia.